153 related articles for article (PubMed ID: 24004467)
1. Expression of CD44v6 and integrin-β1 for the prognosis evaluation of pancreatic cancer patients after cryosurgery.
Zhou G; Chiu D; Qin D; Niu L; Cai J; He L; Tan D; Xu K
Diagn Pathol; 2013 Sep; 8():146. PubMed ID: 24004467
[TBL] [Abstract][Full Text] [Related]
2. The efficacy evaluation of cryosurgery in pancreatic cancer patients with the expression of CD44v6, integrin-β1, CA199, and CEA.
Zhou G; Chiu D; Qin D; Niu L; Cai J; He L; Huang W; Xu K
Mol Biotechnol; 2012 Sep; 52(1):59-67. PubMed ID: 22382453
[TBL] [Abstract][Full Text] [Related]
3. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients.
Li Z; Chen K; Jiang P; Zhang X; Li X; Li Z
Diagn Pathol; 2014 Apr; 9():79. PubMed ID: 24708709
[TBL] [Abstract][Full Text] [Related]
4. Detection and clinical significance of CD44v6 and integrin-β1 in pancreatic cancer patients using a triplex real-time RT-PCR assay.
Zhou G; Chiu D; Qin D; Niu L; Cai J; He L; Huang W; Xu K
Appl Biochem Biotechnol; 2012 Aug; 167(8):2257-68. PubMed ID: 22695923
[TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma.
Zhang H; Gao H; Liu C; Kong Y; Wang C; Zhang H
Diagn Pathol; 2015 Mar; 10():13. PubMed ID: 25890028
[TBL] [Abstract][Full Text] [Related]
6. Low serum levels of soluble CD44 variant 6 are significantly associated with poor prognosis in patients with pancreatic carcinoma.
Gansauge F; Gansauge S; Rau B; Scheiblich A; Poch B; Schoenberg MH; Beger HG
Cancer; 1997 Nov; 80(9):1733-9. PubMed ID: 9351541
[TBL] [Abstract][Full Text] [Related]
7. The establishment of the duplex real-time RT-PCR assay for the detection of CD44v6 in pancreatic cancer patients and clinical application.
Zhou G; Chiu D; Qin D; Niu L; Cai J; He L; Huang W; Xu K
Biotechnol Appl Biochem; 2012; 59(1):55-63. PubMed ID: 22332746
[TBL] [Abstract][Full Text] [Related]
8. Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study.
dos Santos PB; Zanetti JS; Ribeiro-Silva A; Beltrão EI
Diagn Pathol; 2012 Aug; 7():104. PubMed ID: 22894137
[TBL] [Abstract][Full Text] [Related]
9. CD44v6 expression in primary breast carcinoma in western India: a pilot clinicopathologic study.
Shah NG; Trivedi TI; Vora HH; Patel KC; Tankshali R; Goswami JV; Shukla SN; Shah PM
Tumori; 2010; 96(6):971-7. PubMed ID: 21388061
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Tumor Growth and Metastasis in Pancreatic Cancer Models by Interference With CD44v6 Signaling.
Matzke-Ogi A; Jannasch K; Shatirishvili M; Fuchs B; Chiblak S; Morton J; Tawk B; Lindner T; Sansom O; Alves F; Warth A; Schwager C; Mier W; Kleeff J; Ponta H; Abdollahi A; Orian-Rousseau V
Gastroenterology; 2016 Feb; 150(2):513-25.e10. PubMed ID: 26597578
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Implication of Urothelial Stem Cell Markers Differs According to Primary Tumour Location in Non-Muscle-Invasive Bladder Cancer.
Wang L; Zhao J; Yang C; Kuang R; Kazobinka G; Pang Z; Hou T
Cell Physiol Biochem; 2018; 48(6):2364-2373. PubMed ID: 30114689
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiopoietin-1 on attachment and metastasis of human gastric cancer cell line BGC-823.
Ou XL; Chen HJ; Sun WH; Hang C; Yang L; Guan YY; Yan F; Chen BA
World J Gastroenterol; 2009 Nov; 15(43):5432-41. PubMed ID: 19916173
[TBL] [Abstract][Full Text] [Related]
13. Analysis of MAT3 gene expression in NSCLC.
Zheng S; Du Y; Chu H; Chen X; Li P; Wang Y; Ma Y; Wang H; Zang W; Zhang G; Zhao G
Diagn Pathol; 2013 Oct; 8():166. PubMed ID: 24107548
[TBL] [Abstract][Full Text] [Related]
14. Correlation of CD44v6 expression with ovarian cancer progression and recurrence.
Shi J; Zhou Z; Di W; Li N
BMC Cancer; 2013 Apr; 13():182. PubMed ID: 23565736
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD44v6 gene in normal human peripheral blood.
Song J; Zhang DS; Zheng J
World J Gastroenterol; 2005 Jun; 11(23):3591-4. PubMed ID: 15962382
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of β1 integrin expression in colorectal liver metastases.
Vassos N; Rau T; Merkel S; Feiersinger F; Geppert CI; Stürzl M; Hohenberger W; Croner RS
Int J Clin Exp Pathol; 2014; 7(1):288-300. PubMed ID: 24427350
[TBL] [Abstract][Full Text] [Related]
17. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
[TBL] [Abstract][Full Text] [Related]
18. Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment.
Xie Z; Gao Y; Ho C; Li L; Jin C; Wang X; Zou C; Mao Y; Wang X; Li Q; Fu D; Zhang YF
Gut; 2022 Mar; 71(3):568-579. PubMed ID: 33827783
[TBL] [Abstract][Full Text] [Related]
19. Expression of E-selectin, integrin beta1 and immunoglobulin superfamily member in human gastric carcinoma cells and its clinicopathologic significance.
Ke JJ; Shao QS; Ling ZQ
World J Gastroenterol; 2006 Jun; 12(22):3609-11. PubMed ID: 16773720
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer.
Lian S; Zhai X; Wang X; Zhu H; Zhang S; Wang W; Wang Z; Huang J
Medicine (Baltimore); 2016 Jul; 95(30):e4328. PubMed ID: 27472713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
